WILMINGTON, Del. / Aug 16, 2023 / Business Wire / Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has been selected by The Software Report as one of the “Top 100 Software Companies of 2023.” The annual program evaluates companies based on a range of factors, including product functionality, innovative capabilities, environmental, social and governance (ESG) involvement, and long-term viability, among others. This is the second year in a row that Phreesia made the list. Other awardees this year include Adobe, Groove and Pantheon.
“It’s an honor to be recognized as part of this impressive list of software companies,” said Phreesia CEO Chaim Indig. “We feel strongly that our investments in our products and people are furthering our mission to activate patients in their care and drive better health outcomes, and we’re extremely proud to be known as a SaaS innovator in the healthcare space.”
In its announcement, The Software Report called awardees “companies to watch,” noting that “irrespective of the company's size or age, this year’s awardees are making a significant impact on the software industry within their specific domains, all while providing exceptional value to their customers.”
For more information on Phreesia, visit www.phreesia.com.
About Phreesia
Phreesia is the trusted leader in patient activation, giving providers, health plans, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 120 million patient visits in 2022–more than 1 in 10 visits across the U.S.–scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.
Last Trade: | US$23.97 |
Daily Change: | 0.08 0.33 |
Daily Volume: | 468,782 |
Market Cap: | US$1.390B |
March 12, 2025 December 09, 2024 October 28, 2024 October 01, 2024 September 04, 2024 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORECompass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREEnd of content
No more pages to load